Ready to start your GLP-1 journey with GobyMeds
The exact concentration, syringe measurement and dose schedule depend on the prescription and instructions from the dispensing pharmacy
Subcutaneous fat not visceral Patients with large amounts of visceral fat (fat behind the abdominal wall around the organs stomach, intestines, and liver), may not be a good candidate for this procedure
JAMA 330(15):14721483 Li CW, Osman R, Menconi F, Concepcion E, Tomer Y (2020) Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: therapeutic implications to Graves disease
55 In regard to their safety profile, small molecule GLP-1 RAs have also shown similar side effects, being the gastrointestinal symptoms such as nausea, vomiting, and diarrhea the most commonly presented